All News

The study, published in NEJM, found that in addition to supply chain and manufacturing problems, lack of competition may be adding to their costs.

A Kaiser Permanante study surveyed bladder cancer patients and found that current and former smokers were aware of a connection between smoking and their disease.

The cost-value discussion in oncology continues in Europe as NICE lists 40 drugs that it plans to reassess in terms of cost versus patient benefit.

A Republican legislative leader who was a top negotiator in creating Arkansas' private option will be the new governor's chief of staff. The pick is viewed by some as a sign that the private option may have a defender in the incoming administration. Meanwhile, Arkansas' hospitals are highlighting the difference the private option has made in reducing the ranks of uninsured seeking treatment.

A national survey published in JAMA Surgery identified too many repeat surgeries in women with breast cancer.

Following the Supreme Court's decision to hear an appeal for the ACA subsidy lawsuit King v Burwell, a DC appeals court has halted work on a similar case it was reviewing.

As cost containment becomes increasingly important in healthcare, the findings of a recent study in the Annals of Family Medicine on the impacts of continuity of care could have an impact on how healthcare systems deliver care.

Although open enrollment for the Affordable Care Act's insurance Marketplaces is almost here, a 10-question survey from Kaiser Family Foundation found that the health law's target audience still struggles with understanding insurance coverage.

At an ongoing AACR meeting on Health Disparities in cancer, researchers from the Gillings School of Global Public Health presented data showing HPV vaccine uptake among girls is lowest in states with the highest rates of cervical cancer.

Diabetes advocates are pressing for a bill that would compel Medicare to cover CGM technology. They cite a study in The American Journal of Managed Care, which found it costs $17,564 every time a person with diabetes goes to the emergency department with hypoglycemia.

The recommendations by the International Society of Geriatric Oncology, emphasize personalized treatment and assigning a multidisciplinary care team for optimal treatment.

The Affordable Care Act's impact on hospital finances is of decreasing concern, although providers expect trends related to the health law to be a major challenge.

A research group at the Roswell Park Cancer Institute employed 2 different approaches on data generated by The Cancer Genome Atlas, to identify prognostic genes in ovarian cancer.

Hospice care for Medicare patients resulted in lower hospitalization rates and lower healthcare expenditures during the last year of life, according to a study published the November 12 issue of JAMA.

A collaboration between CHOP oncologists and researchers at UPenn aims to provide targeted therapy to children with neuroblastoma, based on their ALK mutation status.

At the annual meeting of the Heart Failure Society of America, cardiologists called for a more broader definition of cancer treatment—related cardiotoxicity.

The managed care wars of the 1990s, when patients complained that health plans would not pay for them to see the doctor of their choice, seem almost quaint in light of today's battles. With the rise of narrow networks, there are new fights about access to doctors, of course. But the more troublesome battles, which are sometimes literally life-threatening, involve access to drugs.

Next month, state health officials will launch a transition of rural Medi-Cal beneficiaries into Medi-Cal managed care health plans. The transition involves about 20,000 of the most frail and elderly segment of the rural Medi-Cal population.

A Phase 3 trial for the drug, TH-302, is currently ongoing.

Traditional pay-for-performance programs tend to result in significant waste for payers, but the industry could benefit from a slightly modified model, which focus efforts on patients who are at higher risk for poor outcomes.

CMS announced today that low-dose computed tomography screening will now be reimbursed once a year by Medicare as a preventive service benefit, despite an advisory panel recommending against the screening back in April 2014.

Open enrollment doesn't begin until Saturday, but the Obama administration is already predicting lower enrollment numbers for the second year of the health insurance exchanges, according to a memo from HHS.

As the healthcare industry transitions to new initiatives such as accountable care organizations and pay-for-performance, clinical documentation improvement is necessary, according to a report from the American Health Information Management Association.

Provenge, approved by the FDA in 2010, faced numerous road-blocks with high cost, limited benefit, and issues with reimbursement rates.

More than a year after its disastrous debut, the federal website HealthCare.gov reopened last night, giving shoppers a few days to browse ahead of the November 15 start date for open enrollment, when consumers will have 60 days to make changes or, for some, select first-time coverage under the Affordable Care Act.

The FDA Oncologic Drugs Advisory Committee voted against recommending panobinostat plus bortezomib and dexamethasone for patients with previously treated multiple myeloma.

In less than 2 months the health insurance Marketplaces will need to be financially self-sustaining, which will occur through a variety of approaches, as federal establishment funds will run out on January 1, 2015.

The treatment, conducted at the University of Pennsylvania, identified a mutation in the BRaf gene which is commonly mutated in melanoma. Subsequent treatment with dabrafenib and trametinib resulted in rapid tumor shrinkage.

Based on data from 17 states and the District of Columbia, premium increases for 2015 are expected to be low, according to a report from The Urban Institute.

On the heels of a major Republican victory in the midterm elections, the Supreme Court has decided to review the latest challenge to the Affordable Care Act.